BPC 157: Miracle Healing Peptide or Hidden Danger? FDA to weigh easing limits on unproven peptides The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Moves to Reevaluate Several Peptides American Med Spa Association Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC 157 Ligament: 1 Unsafe Truth